Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 580

1.

Smoking and the risk for bipolar disorder: evidence from a bidirectional Mendelian randomisation study.

Vermeulen JM, Wootton RE, Treur JL, Sallis HM, Jones HJ, Zammit S, van den Brink W, Goodwin GM, de Haan L, Munafò MR.

Br J Psychiatry. 2019 Sep 17:1-7. doi: 10.1192/bjp.2019.202. [Epub ahead of print]

PMID:
31526406
2.

Current and Future Nutritional Strategies to Modulate Inflammatory Dynamics in Metabolic Disorders.

van den Brink W, van Bilsen J, Salic K, Hoevenaars FPM, Verschuren L, Kleemann R, Bouwman J, Ronnett GV, van Ommen B, Wopereis S.

Front Nutr. 2019 Aug 26;6:129. doi: 10.3389/fnut.2019.00129. eCollection 2019. Review.

3.

Whole Grain Wheat Consumption Affects Postprandial Inflammatory Response in a Randomized Controlled Trial in Overweight and Obese Adults with Mild Hypercholesterolemia in the Graandioos Study.

Hoevenaars FPM, Esser D, Schutte S, Priebe MG, Vonk RJ, van den Brink WJ, van der Kamp JW, Stroeve JHM, Afman LA, Wopereis S.

J Nutr. 2019 Aug 27. pii: nxz177. doi: 10.1093/jn/nxz177. [Epub ahead of print]

PMID:
31504709
4.

Trends in use and misuse of opioids in the Netherlands: a retrospective, multi-source database study.

Kalkman GA, Kramers C, van Dongen RT, van den Brink W, Schellekens A.

Lancet Public Health. 2019 Aug 20. pii: S2468-2667(19)30128-8. doi: 10.1016/S2468-2667(19)30128-8. [Epub ahead of print]

5.

[International consensus for the screening, diagnosis and treatment of adult patients with substance use disorder and ADHD].

Crunelle CL, van den Brink W, Schellekens A, van de Glind G, Icasa Consortium B, Matthys F.

Tijdschr Psychiatr. 2019;61(7):477-487. Dutch.

6.

The Unhealthy Chicken or the Unhealthy Egg: Quitting Smoking Matters: Response to Hajek et al.

Vermeulen JM, van den Brink W, de Haan L.

Am J Psychiatry. 2019 Jul 1;176(7):575-576. doi: 10.1176/appi.ajp.2019.18111257r. No abstract available.

PMID:
31256619
7.

Between-hospital variation in mortality and survival after glioblastoma surgery in the Dutch Quality Registry for Neuro Surgery.

De Witt Hamer PC, Ho VKY, Zwinderman AH, Ackermans L, Ardon H, Boomstra S, Bouwknegt W, van den Brink WA, Dirven CM, van der Gaag NA, van der Veer O, Idema AJS, Kloet A, Koopmans J, Ter Laan M, Verstegen MJT, Wagemakers M, Robe PAJT; Quality Registry Neuro Surgery glioblastoma working group from the Dutch Society of Neurosurgery.

J Neurooncol. 2019 Sep;144(2):313-323. doi: 10.1007/s11060-019-03229-5. Epub 2019 Jun 24.

8.

The Effect of High-Frequency Repetitive Transcranial Magnetic Stimulation on Emotion Processing, Reappraisal, and Craving in Alcohol Use Disorder Patients and Healthy Controls: A Functional Magnetic Resonance Imaging Study.

Jansen JM, van den Heuvel OA, van der Werf YD, de Wit SJ, Veltman DJ, van den Brink W, Goudriaan AE.

Front Psychiatry. 2019 May 7;10:272. doi: 10.3389/fpsyt.2019.00272. eCollection 2019.

9.

High-potency cannabis and incident psychosis: correcting the causal assumption.

Sommer IE, van den Brink W.

Lancet Psychiatry. 2019 Jun;6(6):464-465. doi: 10.1016/S2215-0366(19)30130-0. No abstract available.

PMID:
31122471
10.

Emotion Processing, Reappraisal, and Craving in Alcohol Dependence: A Functional Magnetic Resonance Imaging Study.

Jansen JM, van den Heuvel OA, van der Werf YD, de Wit SJ, Veltman DJ, van den Brink W, Goudriaan AE.

Front Psychiatry. 2019 Apr 9;10:227. doi: 10.3389/fpsyt.2019.00227. eCollection 2019.

11.

Defining Compulsive Behavior.

Luigjes J, Lorenzetti V, de Haan S, Youssef GJ, Murawski C, Sjoerds Z, van den Brink W, Denys D, Fontenelle LF, Yücel M.

Neuropsychol Rev. 2019 Mar;29(1):4-13. doi: 10.1007/s11065-019-09404-9. Epub 2019 Apr 23. Review.

12.

Diagnosis and treatment of patients with comorbid substance use disorder and adult attention-deficit and hyperactivity disorder: a review of recent publications.

van der Burg D, Crunelle CL, Matthys F, van den Brink W.

Curr Opin Psychiatry. 2019 Jul;32(4):300-306. doi: 10.1097/YCO.0000000000000513.

PMID:
31008730
13.

Influence of Gamma-Hydroxybutyric Acid-Use and Gamma-Hydroxybutyric Acid-Induced Coma on Affect and the Affective Network.

Raposo Pereira F, McMaster MTB, de Vries YDAT, Polderman N, van den Brink W, van Wingen GA.

Eur Addict Res. 2019;25(4):173-181. doi: 10.1159/000497381. Epub 2019 Apr 18.

PMID:
30999293
14.

VMAT2 gene (SLC18A2) variants associated with a greater risk for developing opioid dependence.

Randesi M, van den Brink W, Levran O, Blanken P, van Ree JM, Ott J, Kreek MJ.

Pharmacogenomics. 2019 Apr;20(5):331-341. doi: 10.2217/pgs-2018-0137. Epub 2019 Apr 15.

PMID:
30983500
15.

Association of variants of prodynorphin promoter 68-bp repeats in caucasians with opioid dependence diagnosis: Effect on age trajectory of heroin use.

Yuferov V, Randesi M, Butelman ER, van den Brink W, Blanken P, van Ree JM, Ott J, Kreek MJ.

Neurosci Lett. 2019 Jun 21;704:100-105. doi: 10.1016/j.neulet.2019.03.038. Epub 2019 Mar 29.

PMID:
30936032
16.

Potential influence of socioeconomic status on genetic correlations between alcohol consumption measures and mental health.

Marees AT, Smit DJA, Ong JS, MacGregor S, An J, Denys D, Vorspan F, van den Brink W, Derks EM.

Psychol Med. 2019 Mar 15:1-15. doi: 10.1017/S0033291719000357. [Epub ahead of print]

PMID:
30874500
17.

Integrated cognitive behavioral therapy for ADHD in adult substance use disorder patients: Results of a randomized clinical trial.

van Emmerik-van Oortmerssen K, Vedel E, Kramer FJ, Blankers M, Dekker JJM, van den Brink W, Schoevers RA.

Drug Alcohol Depend. 2019 Apr 1;197:28-36. doi: 10.1016/j.drugalcdep.2018.12.023. Epub 2019 Feb 5.

PMID:
30769263
18.

Recreational use of GHB is associated with alterations of resting state functional connectivity of the central executive and default mode networks.

Raposo Pereira F, Zhutovsky P, Mcmaster MTB, Polderman N, de Vries YDAT, van den Brink W, van Wingen GA.

Hum Brain Mapp. 2019 Jun 1;40(8):2413-2421. doi: 10.1002/hbm.24532. Epub 2019 Feb 5.

19.

Blood-Based Biomarkers of Quinpirole Pharmacology: Cluster-Based PK/PD and Metabolomics to Unravel the Underlying Dynamics in Rat Plasma and Brain.

van den Brink WJ, Hartman R, van den Berg DJ, Flik G, Gonzalez-Amoros B, Koopman N, Elassais-Schaap J, van der Graaf PH, Hankemeier T, de Lange ECM.

CPT Pharmacometrics Syst Pharmacol. 2019 Feb;8(2):107-117. doi: 10.1002/psp4.12370. Epub 2019 Jan 24.

20.

The Use of Baclofen as a Treatment for Alcohol Use Disorder: A Clinical Practice Perspective.

de Beaurepaire R, Sinclair JMA, Heydtmann M, Addolorato G, Aubin HJ, Beraha EM, Caputo F, Chick JD, de La Selle P, Franchitto N, Garbutt JC, Haber PS, Jaury P, Lingford-Hughes AR, Morley KC, Müller CA, Owens L, Pastor A, Paterson LM, Pélissier F, Rolland B, Stafford A, Thompson A, van den Brink W, Leggio L, Agabio R.

Front Psychiatry. 2019 Jan 4;9:708. doi: 10.3389/fpsyt.2018.00708. eCollection 2018. Review.

21.

Correction: The use and helpfulness of self-management strategies for depression: The experiences of patients.

van Grieken RA, van Tricht MJ, Koeter MWJ, van den Brink W, Schene AH.

PLoS One. 2018 Dec 13;13(12):e0209109. doi: 10.1371/journal.pone.0209109. eCollection 2018.

22.

Effects of Methylphenidate During Fear Learning in Antisocial Adolescents: A Randomized Controlled fMRI Trial.

van Lith K, Veltman DJ, Cohn MD, Pape LE, van den Akker-Nijdam ME, van Loon AWG, Bet P, van Wingen GA, van den Brink W, Doreleijers T, Popma A.

J Am Acad Child Adolesc Psychiatry. 2018 Dec;57(12):934-943. doi: 10.1016/j.jaac.2018.06.026. Epub 2018 Sep 26.

PMID:
30522739
23.

Smoking, symptoms, and quality of life in patients with psychosis, siblings, and healthy controls: a prospective, longitudinal cohort study.

Vermeulen J, Schirmbeck F, Blankers M, van Tricht M, van den Brink W, de Haan L; Genetic Risk and Outcome of Psychosis (GROUP) investigators.

Lancet Psychiatry. 2019 Jan;6(1):25-34. doi: 10.1016/S2215-0366(18)30424-3. Epub 2018 Dec 5. Erratum in: Lancet Psychiatry. 2019 Feb;6(2):e5.

PMID:
30527763
24.

Self-wise, Other-wise, Streetwise (SOS) training, an intervention to prevent victimization in dual-diagnosis patients: results from a randomized clinical trial.

de Waal MM, Dekker JJM, Kikkert MJ, Christ C, Chmielewska J, Staats MWM, van den Brink W, Goudriaan AE.

Addiction. 2019 Apr;114(4):730-740. doi: 10.1111/add.14500. Epub 2018 Dec 18.

25.

Use of the Fagerström test to assess differences in the degree of nicotine dependence in smokers from five ethnic groups: The HELIUS study.

van Amsterdam J, Vorspan F, Snijder MB, van den Brink W, Schene AH, Stronks K, Galenkamp H, Derks EM.

Drug Alcohol Depend. 2019 Jan 1;194:197-204. doi: 10.1016/j.drugalcdep.2018.10.011. Epub 2018 Nov 6.

PMID:
30447512
26.

Baclofen for the treatment of alcohol use disorder: the Cagliari Statement.

Agabio R, Sinclair JM, Addolorato G, Aubin HJ, Beraha EM, Caputo F, Chick JD, de La Selle P, Franchitto N, Garbutt JC, Haber PS, Heydtmann M, Jaury P, Lingford-Hughes AR, Morley KC, Müller CA, Owens L, Pastor A, Paterson LM, Pélissier F, Rolland B, Stafford A, Thompson A, van den Brink W, de Beaurepaire R, Leggio L.

Lancet Psychiatry. 2018 Dec;5(12):957-960. doi: 10.1016/S2215-0366(18)30303-1. Epub 2018 Nov 6. No abstract available.

27.

The use and helpfulness of self-management strategies for depression: The experiences of patients.

van Grieken RA, van Tricht MJ, Koeter MWJ, van den Brink W, Schene AH.

PLoS One. 2018 Oct 25;13(10):e0206262. doi: 10.1371/journal.pone.0206262. eCollection 2018. Erratum in: PLoS One. 2018 Dec 13;13(12):e0209109.

28.

Effect of GHB-use and GHB-induced comas on dorsolateral prefrontal cortex functioning in humans.

Raposo Pereira F, McMaster MTB, Polderman N, de Vries YDAT, van den Brink W, van Wingen GA.

Neuroimage Clin. 2018;20:923-930. doi: 10.1016/j.nicl.2018.09.022. Epub 2018 Sep 26.

29.

Acceptance of pharmaceutical cannabis substitution by cannabis using patients with schizophrenia.

van Amsterdam J, Vervloet J, de Weert G, Buwalda VJA, Goudriaan AE, van den Brink W.

Harm Reduct J. 2018 Sep 20;15(1):47. doi: 10.1186/s12954-018-0253-7.

30.

Pregabalin and the Risk for Opioid-Related Death: A Nested Case-Control Study.

Gomes T, Greaves S, van den Brink W, Antoniou T, Mamdani MM, Paterson JM, Martins D, Juurlink DN.

Ann Intern Med. 2018 Nov 20;169(10):732-734. doi: 10.7326/M18-1136. Epub 2018 Aug 21. No abstract available.

PMID:
30140853
31.

Association Between Smoking Behavior and Cognitive Functioning in Patients With Psychosis, Siblings, and Healthy Control Subjects: Results From a Prospective 6-Year Follow-Up Study.

Vermeulen JM, Schirmbeck F, Blankers M, van Tricht M, Bruggeman R, van den Brink W, de Haan L; Genetic Risk and Outcome of Psychosis (GROUP) investigators.

Am J Psychiatry. 2018 Nov 1;175(11):1121-1128. doi: 10.1176/appi.ajp.2018.18010069. Epub 2018 Aug 2.

PMID:
30138044
32.

A transdiagnostic dimensional approach towards a neuropsychological assessment for addiction: an international Delphi consensus study.

Yücel M, Oldenhof E, Ahmed SH, Belin D, Billieux J, Bowden-Jones H, Carter A, Chamberlain SR, Clark L, Connor J, Daglish M, Dom G, Dannon P, Duka T, Fernandez-Serrano MJ, Field M, Franken I, Goldstein RZ, Gonzalez R, Goudriaan AE, Grant JE, Gullo MJ, Hester R, Hodgins DC, Le Foll B, Lee RSC, Lingford-Hughes A, Lorenzetti V, Moeller SJ, Munafò MR, Odlaug B, Potenza MN, Segrave R, Sjoerds Z, Solowij N, van den Brink W, van Holst RJ, Voon V, Wiers R, Fontenelle LF, Verdejo-Garcia A.

Addiction. 2019 Jun;114(6):1095-1109. doi: 10.1111/add.14424. Epub 2018 Oct 5.

33.

Fingerprints of CNS drug effects: a plasma neuroendocrine reflection of D2 receptor activation using multi-biomarker pharmacokinetic/pharmacodynamic modelling.

van den Brink WJ, van den Berg DJ, Bonsel FEM, Hartman R, Wong YC, van der Graaf PH, de Lange ECM.

Br J Pharmacol. 2018 Oct;175(19):3832-3843. doi: 10.1111/bph.14452. Epub 2018 Aug 31.

34.

Efficacy and safety of sodium oxybate in alcohol-dependent patients with a very high drinking risk level.

van den Brink W, Addolorato G, Aubin HJ, Benyamina A, Caputo F, Dematteis M, Gual A, Lesch OM, Mann K, Maremmani I, Nutt D, Paille F, Perney P, Rehm J, Reynaud M, Simon N, Söderpalm B, Sommer WH, Walter H, Spanagel R.

Addict Biol. 2018 Jul;23(4):969-986. doi: 10.1111/adb.12645.

PMID:
30043457
35.

[New indications for existing drugs; repurposing in psychiatry and addiction medicine].

Strous JFM, van den Brink W.

Ned Tijdschr Geneeskd. 2018 May 2;162. pii: D2354. Dutch.

PMID:
30020573
36.

N-acetyl cysteine in the treatment of alcohol use disorder in patients with liver disease: Rationale for further research.

Morley KC, Baillie A, Van Den Brink W, Chitty KE, Brady K, Back SE, Seth D, Sutherland G, Leggio L, Haber PS.

Expert Opin Investig Drugs. 2018 Aug;27(8):667-675. doi: 10.1080/13543784.2018.1501471. Epub 2018 Aug 1. Review.

PMID:
30019966
37.

Post-lumbar discectomy reoperations that are associated with poor clinical and socioeconomic outcomes can be reduced through use of a novel annular closure device: results from a 2-year randomized controlled trial.

Klassen PD, Hsu WK, Martens F, Inzana JA, van den Brink WA, Groff MW, Thomé C.

Clinicoecon Outcomes Res. 2018 Jun 26;10:349-357. doi: 10.2147/CEOR.S164129. eCollection 2018.

38.

Adverse effects of GHB-induced coma on long-term memory and related brain function.

Raposo Pereira F, McMaster MTB, Polderman N, de Vries YDAT, van den Brink W, van Wingen GA.

Drug Alcohol Depend. 2018 Sep 1;190:29-36. doi: 10.1016/j.drugalcdep.2018.05.019. Epub 2018 Jun 26.

39.

Intoxicated aggression: Do alcohol and stimulants cause dose-related aggression? A review.

Kuypers K, Verkes RJ, van den Brink W, van Amsterdam J, Ramaekers JG.

Eur Neuropsychopharmacol. 2018 Jun 22. pii: S0924-977X(18)30147-0. doi: 10.1016/j.euroneuro.2018.06.001. [Epub ahead of print]

PMID:
29941239
40.

Efficacy, tolerability, and safety of low-dose and high-dose baclofen in the treatment of alcohol dependence: A systematic review and meta-analysis.

Pierce M, Sutterland A, Beraha EM, Morley K, van den Brink W.

Eur Neuropsychopharmacol. 2018 Jul;28(7):795-806. doi: 10.1016/j.euroneuro.2018.03.017. Epub 2018 Jun 20.

PMID:
29934090
41.

Exploring the role of low-frequency and rare exonic variants in alcohol and tobacco use.

Marees AT, Hammerschlag AR, Bastarache L, de Kluiver H, Vorspan F, van den Brink W, Smit DJ, Denys D, Gamazon ER, Li-Gao R, Breetvelt EJ, de Groot MCH, Galesloot TE, Vermeulen SH, Poppelaars JL, Souverein PC, Keeman R, de Mutsert R, Noordam R, Rosendaal FR, Stringa N, Mook-Kanamori DO, Vaartjes I, Kiemeney LA, den Heijer M, van Schoor NM, Klungel OH, Maitland-Van der Zee AH, Schmidt MK, Polderman TJC, van der Leij AR, Posthuma D, Derks EM.

Drug Alcohol Depend. 2018 Jul 1;188:94-101. doi: 10.1016/j.drugalcdep.2018.03.026. Epub 2018 Apr 25.

42.

Annular closure in lumbar microdiscectomy for prevention of reherniation: a randomized clinical trial.

Thomé C, Klassen PD, Bouma GJ, Kuršumović A, Fandino J, Barth M, Arts M, van den Brink W, Bostelmann R, Hegewald A, Heidecke V, Vajkoczy P, Fröhlich S, Wolfs J, Assaker R, Van de Kelft E, Köhler HP, Jadik S, Eustacchio S, Hes R, Martens F; Annular Closure RCT Study Group.

Spine J. 2018 Dec;18(12):2278-2287. doi: 10.1016/j.spinee.2018.05.003. Epub 2018 May 3.

43.

The relation between gray matter volume and the use of alcohol, tobacco, cocaine and cannabis in male polysubstance users.

Kaag AM, Schulte MHJ, Jansen JM, van Wingen G, Homberg J, van den Brink W, Wiers RW, Schmaal L, Goudriaan AE, Reneman L.

Drug Alcohol Depend. 2018 Jun 1;187:186-194. doi: 10.1016/j.drugalcdep.2018.03.010. Epub 2018 Apr 15.

44.

Reprint of The effect of N-acetylcysteine and working memory training on cocaine use, craving and inhibition in regular cocaine users: correspondence of lab assessments and Ecological Momentary Assessment.

Schulte MHJ, Wiers RW, Boendermaker WJ, Goudriaan AE, van den Brink W, van Deursen DS, Friese M, Brede E, Waters AJ.

Addict Behav. 2018 Aug;83:79-86. doi: 10.1016/j.addbeh.2018.03.023. Epub 2018 Mar 26.

PMID:
29661657
45.

Pharmacokinetics of Sustained-Release Oral Dexamphetamine Sulfate in Cocaine and Heroin-Dependent Patients.

Herbrink M, Nuijten M, Nuijen B, Huitema ADR, Beijnen JH, Hendriks VM, Blanken P, Janmohamed A, van den Brink W.

J Clin Psychopharmacol. 2018 Jun;38(3):212-217. doi: 10.1097/JCP.0000000000000862.

PMID:
29620701
46.

Enhanced Amygdala-Striatal Functional Connectivity during the Processing of Cocaine Cues in Male Cocaine Users with a History of Childhood Trauma.

Kaag AM, Reneman L, Homberg J, van den Brink W, van Wingen GA.

Front Psychiatry. 2018 Mar 12;9:70. doi: 10.3389/fpsyt.2018.00070. eCollection 2018.

47.

Correction to: Access to the CNS: Biomarker Strategies for DopaminergicTreatments.

van den Brink WJ, Palic S, Kohler I, de Lange ECM.

Pharm Res. 2018 Mar 19;35(5):102. doi: 10.1007/s11095-018-2388-3.

PMID:
29556786
48.

[Personalised treatment of disorders in the use of alcohol and nicotine].

Dom G, van den Brink W, Schellekens A.

Tijdschr Psychiatr. 2018;60(3):166-173. Review. Dutch.

49.

Bundling arrows: improving translational CNS drug development by integrated PK/PD-metabolomics.

van den Brink WJ, Hankemeier T, van der Graaf PH, de Lange ECM.

Expert Opin Drug Discov. 2018 Jun;13(6):539-550. doi: 10.1080/17460441.2018.1446935. Epub 2018 Mar 8. Review.

PMID:
29519169
50.

International Consensus Statement on Screening, Diagnosis and Treatment of Substance Use Disorder Patients with Comorbid Attention Deficit/Hyperactivity Disorder.

Crunelle CL, van den Brink W, Moggi F, Konstenius M, Franck J, Levin FR, van de Glind G, Demetrovics Z, Coetzee C, Luderer M, Schellekens A; ICASA consensus group, Matthys F.

Eur Addict Res. 2018;24(1):43-51. doi: 10.1159/000487767. Epub 2018 Mar 6.

Supplemental Content

Loading ...
Support Center